Search hospitals > Florida > West Palm Beach
Florida Cancer Specialists
Claim this profileWest Palm Beach, Florida 33401
Global Leader in Lung Cancer
Global Leader in Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
Conducts research for Cancer
Conducts research for Lymphoma
126 reported clinical trials
8 medical researchers
Summary
Florida Cancer Specialists is a medical facility located in West Palm Beach, Florida. This center is recognized for care of Lung Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Cancer, Lymphoma and other specialties. Florida Cancer Specialists is involved with conducting 126 clinical trials across 128 conditions. There are 8 research doctors associated with this hospital, such as Viralkumar Bhanderi, Shachar Peles, Todd Gersten, and Eric Harris.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
EGFR positive
Top PIs
Viralkumar BhanderiFlorida Cancer Specialists5 years of reported clinical research
Studies Lymphoma
Studies Cancer
13 reported clinical trials
42 drugs studied
Shachar PelesFlorida Cancer Specialists East3 years of reported clinical research
Studies Lymphoma
Studies Multiple Myeloma
10 reported clinical trials
41 drugs studied
Todd GerstenFlorida Cancer Specialists - East5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
15 drugs studied
Eric HarrisFlorida Cancer Specialists7 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
7 drugs studied
Clinical Trials running at Florida Cancer Specialists
Non-Small Cell Lung Cancer
Colorectal Cancer
Lung Cancer
Endometrial Cancer
Multiple Myeloma
Cancer
Lymphoma
Follicular Lymphoma
Breast Cancer
Plasma Cell Neoplasm
Divarasib vs Other Treatments
for Lung Cancer
The purpose of this study is to assess the safety and efficacy of divarasib compared to locally approved KRAS G12C inhibitors (sotorasib or adagrasib) in participants with KRAS G12C-positive (KRAS G12C +) advanced or metastatic non-small cell lung cancer (NSCLC).
Recruiting2 awards Phase 35 criteria
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting2 awards Phase 310 criteria
Nivolumab + Relatlimab vs Pembrolizumab with Chemotherapy
for Lung Cancer
The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV or recurrent Non-squamous Non-small Cell Lung Cancer with PD-L1 expression ≥ 1%
Recruiting2 awards Phase 33 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Florida Cancer Specialists?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.